Aclaris Therapeutics, Inc.

ACRS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001557746

SEC filings (opens in a new tab)

No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Aclaris Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of ACRS: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	126	2	133	+9
Shares	56.8M	4.60K	56.0M	−736.0K (−1.3%)
Value	$1.02B	$83.0K	$814.9M	−$207.2M (−20.3%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ACRS in Q4 2021
Institution	Shares	Value	% of portfolio
TCG Crossover Management, LLC	1,082,213	$15.7M	7.37%
Verition Fund Management LLC	178,310	$2.59M	0.03%
Hamilton Lane Advisors LLC	97,550	$1.42M	0.18%
Ameriprise Financial Inc	74,258	$1.08M	0.00%
Tri Locum Partners LP	55,433	$806.0K	0.32%
Pura Vida Investments, LLC	48,266	$702.0K	0.07%
Jump Financial, LLC	32,000	$465.0K	0.03%
Sender Co & Partners, Inc.	30,132	$438.0K	0.28%
Engineers Gate Manager LP	27,453	$399.0K	0.02%
Martingale Asset Management L P	23,702	$345.0K	0.00%
Alpine Global Management, LLC	20,528	$298.0K	0.04%
DekaBank Deutsche Girozentrale	20,000	$288.0K	0.00%
ProShare Advisors LLC	19,760	$287.0K	0.00%
Fox Run Management, L.L.C.	19,368	$282.0K	0.17%
Old Mission Capital LLC	15,663	$228.0K	0.01%
Trexquant Investment LP	14,587	$212.0K	0.01%
Handelsbanken Fonder AB	13,800	$201.0K	0.00%
Dynamic Technology Lab Private Ltd	13,873	$201.0K	0.02%
Blackstone Group Inc.	13,033	$189.0K	0.00%
Boulder Hill Capital Management LP	11,200	$163.0K	0.16%
Ensign Peak Advisors, Inc	10,970	$160.0K	0.00%
Hyperion Capital Advisors LP	10,861	$158.0K	0.04%
Walleye Capital LLC	10,341	$150.0K	0.00%
Allspring Global Investments Holdings, LLC	8,559	$124.0K	0.00%
Point72 Hong Kong Ltd	1,784	$26.0K	0.00%
Daiwa Securities Group Inc.	179	$3.00K	0.00%
Signaturefd, LLC	63	$1.00K	0.00%
IFP Advisors, Inc	5	–	–

Sold out (19)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ACRS in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Foresite Capital Management III, LLC	1,954,904	$35.2M
Woodline Partners LP	594,768	$10.7M
Assenagon Asset Management S.A.	473,365	$8.52M
J. Goldman & Co LP	177,740	$3.20M
Jetstream Capital LLC	140,000	$2.52M
Bank of Montreal	87,005	$1.57M
Endurant Capital Management LP	67,300	$1.21M
AlphaCrest Capital Management LLC	35,000	$630.0K
Atom Investors LP	25,197	$454.0K
Dimensional Fund Advisors LP	18,640	$336.0K
Squarepoint Ops LLC	15,834	$285.0K
Marshall Wace, LLP	13,619	$245.0K
Baker Tilly Wealth Management, LLC	11,773	$212.0K
Tudor Investment Corp Et Al	10,539	$190.0K
STRS Ohio	6,700	$120.0K
Meeder Asset Management Inc	2,383	$43.0K
Quantbot Technologies LP	765	$13.0K
O'Shaughnessy Asset Management, LLC	288	$5.00K
Brewin Dolphin Ltd	195	$3.51K

Not filed for Q4 2021 yet (2)

Institutions that held Aclaris Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACRS in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
First Mercantile Trust Co	4,433	$80.0K
Berman Capital Advisors, LLC	170	$3.00K